川發龍蟒(002312.SZ):攀枝花項目首期5萬噸磷酸鐵主要裝置廠房基礎已完成
格隆匯1月18日丨川發龍蟒(002312.SZ)在接待機構投資者調研時表示,目前公司德阿項目各項工作有序推進中,首期2萬噸磷酸鐵鋰裝置已正常生產,開始開展送樣工作;攀枝花項目首期5萬噸磷酸鐵主要裝置廠房基礎已完成,尚未投產。公司多次召開戰略反思會,密切關注行業週期變化,高度關注投資進度,審慎推進旗下新能源材料項目落實落地,當前主要工作不是擴大規模,而是做好產品質量,積極建立銷售渠道、給下游客户送樣,為後期銷售做好準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.